CBLL

CeriBell, Inc. - Common Stock (CBLL)

About CeriBell, Inc. - Common Stock (CBLL)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Details

Daily high
$28.00
Daily low
$25.80
Price at open
$27.39
52 Week High
$28.89
52 Week Low
$11.26
Market cap
1.1B
Dividend yield
-
Volume
955,786
Avg. volume
632,749
P/E ratio
-14.06

CeriBell, Inc. - Common Stock News

Details

Daily high
$28.00
Daily low
$25.80
Price at open
$27.39
52 Week High
$28.89
52 Week Low
$11.26
Market cap
1.1B
Dividend yield
-
Volume
955,786
Avg. volume
632,749
P/E ratio
-14.06